Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
Pituitary 101: Episode 8
In this episode Dr. Blevins reviews the physiological factors that regulate the secretion of Growth Hormone and discusses tests to evaluate disorders in its secretion.
Hypopituitarism; an essential guide is available now!
We are excited to announce the latest book by Lewis S. Blevins, Jr., M.D., published by Pituitary World News. In this third installment, Dr. Blevins shares his expert approach to evaluating and managing hypopituitarism, offering insights to optimize patient treatment and well-being.
Worth noting:
Corcept Therapeutics announces FDA Relacolirant new drug application to treat Hypercortisolism . Read more
From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more
Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more
News from Recordati on osilodrostat for endogenous Cushing’s – More details here
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
Apple Podcasts
Spotify
Amazon Music
Google PodcastsEvents
